Moolec Science (MLEC) Change in Account Payables (2023 - 2026)
Moolec Science's (MLEC) quarterly Change in Account Payables came in at $7.2 million in Q1 2026, up 1.98% quarter-over-quarter from $7.1 million in Q4 2025.
Moolec Science (MLEC) Change in Account Payables (2023 - 2026) Analysis & Trends
Moolec Science has disclosed Change in Account Payables across 4 years of filings, most recently posting $7.2 million for Q1 2026.
- Change in Account Payables for Q1 2026 came in at $7.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (changed N/A YoY), and the FY2025 annual result was $7.3 million, down 95.66% from the prior year.
- Change in Account Payables came in at $7.2 million for Q1 2026 at Moolec Science, up from $7.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $168.9 million in Q2 2024 to a low of $4.3 million in Q3 2024.
- The 4-year median for Change in Account Payables is $7.2 million (2026), against an average of $55.6 million.
- Across the five-year window, Change in Account Payables surged 2412.68% in 2024 and slumped 95.66% in 2025, its largest moves.
- Moolec Science's Change in Account Payables stood at $5.7 million in 2023, then soared by 2412.68% to $144.1 million in 2024, then plunged by 95.1% to $7.1 million in 2025, then rose by 1.98% to $7.2 million in 2026.
- The last three Change in Account Payables figures came in at $7.2 million (Q1 2026), $7.1 million (Q4 2025), and $7.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -9.42 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.20 Mn |
| Mar 31, 2026 | 7.20 Mn |
| Dec 31, 2025 | 7.06 Mn |
| Dec 31, 2025 | 7.06 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Dec 31, 2024 | 144.08 Mn |
| Dec 31, 2024 | 144.08 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 168.94 Mn |
| Jun 30, 2024 | 168.94 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 5.73 Mn |
| Dec 31, 2023 | 5.73 Mn |
| Jun 30, 2023 | 151.52 Mn |
| Jun 30, 2023 | 151.52 Mn |